Reducing Risk in the Treatment of Attention-Deficit/Hyperactivity Disorder Among Adults With Comorbidities

Author:

Kverno Karan,Ramos-Marcuse Fatima

Abstract

Recent widely publicized shortages in the U.S. supply of first-line medications for treatment of attention-deficit/hyperactivity disorder (ADHD) are thought to reflect increases in public awareness, help seeking, and treatment. ADHD is one of the most common neurodevelopmental disorders and is typically identified in childhood. In adulthood, ADHD symptoms are less likely to include hyperactivity, but inattention, impulsivity, and emotional dysregulation are common. Clinical evaluation of symptomatic adults who were not diagnosed as children requires corroboration of ADHD diagnostic symptoms in childhood and careful differentiation of ADHD from frequently co-occurring psychiatric and substance use disorders. Treatment of adult ADHD can result in improved functioning across multiple dimensions and comorbid disorders. Existing guidelines and consensus statements recommend an integrated approach to treating ADHD and all existing comorbid disorders, prioritizing the disorder that is creating the most difficulty for the individual. [ Journal of Psychosocial Nursing and Mental Health Services, 62 (1), 8–11.]

Publisher

SLACK, Inc.

Subject

Pshychiatric Mental Health,General Nursing

Reference33 articles.

1. The Effects of Nicotine and Tobacco Use on Brain Reward Function: Interaction With Nicotine Dependence Severity

2. American Professional Society of ADHD and Related Disorders. (2023, August). The first U.S. guidelines for adult ADHD to be released by the American Professional Society of ADHD and related disorders (APSARD.org). https://apsard.org/wp-content/uploads/2022/08/APSARD-Adult-ADHD-Guidelines-Press-Release.pdf

3. Diagnostic and Statistical Manual of Mental Disorders

4. Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician

5. Barkley, R. A. (2011). Barkley Adult ADHD Rating Scale-IV (BAARS-IV)s. The Guilford Press.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3